“Calling All Investors: Don’t Miss Your Chance to Take the Lead in the Kyverna Therapeutics Inc. Securities Lawsuit!”
Welcome to Rosen Law Firm Your Rights Matter Important Deadlines for Kyverna Therapeutics Investors NEW YORK, Feb. 1, 2025 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, is here to remind purchasers of common stock of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) about the upcoming February 7, 2025 lead plaintiff deadline. If you…